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Abstract 
Cutis laxa is a rare disease characterized by abnormal skin wrinkling and laxity, due to de-
creased elastin synthesis or structural extracellular matrix defects. We have explored elastin 
metabolism in a case of adult onset cutis laxa localized to the upper body of a woman. For 
this purpose, we obtained skin biopsies from affected and unaffected skin areas of the pa-
tient and analyzed these with microscopy, polymerase chain reaction, western blotting and 
cell culture experiments. Skin from the affected area lacked elastin fibers in electron micros-
copy but had higher mRNA expression of elastin and total RNA. Levels of an apparent tropo-
elastin degradation product were higher in the affected area. Fibroblast cultures from the 
affected area were able to produce elastin and showed higher proliferation and survival after 
oxidative and UVB stress compared to fibroblasts from the unaffected area. In conclusion, we 
report a case of acquired localized cutis laxa with a lack of elastic fibers in the skin of the 
patient’s upper body. The lack of elastic fibers in the affected skin was combined with in-
creased mRNA expression and protein levels of elastin. These findings indicate that elastin 
synthesis was increased but did not lead to deposited elastic fibers in the tissue. 
 © 2016 The Author(s) 
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Introduction 
Cutis laxa is a rare disease that leads to a loss of the elastic properties of the skin and 
possible systemic involvement of other organ systems. The skin appears wrinkled, sagging 
and inelastic. The disease exists in a congenital form and in an acquired form, which can both 
be generalized or localized [1]. Cutis laxa is caused by defects in the synthesis of elastin or by 
structural defects in the extracellular matrix, and many different types of mutations have 
been described in the congenital form of cutis laxa [2]. The acquired form is rarer and may 
occur as a postinflammatory phenomenon after urticaria, for example [3, 4]. Acquired local-
ized cutis laxa is very rare, but of particular interest as it may help elucidate the relationship 
between local and systemic pathogenic factors [5]. 
Case Presentation 
We report a 30-year-old female that gradually developed severe cosmetically disabling 
wrinkling of the skin of her upper body over 5 years. Face, neck, breast and upper arms were 
the most affected areas (fig. 1), whereas the lower extremities were clinically completely 
unaffected. Prior to the skin changes, she had achieved an intended weight loss of 20 kg (BMI 
at the time of examination was 30). The onset of the skin changes coincided with an episode 
of urticaria of unexplained origin. Based on her history, clinical presentation and histo-
pathology, the patient was diagnosed with cutis laxa. She had no family history of cutis laxa, 
but her mother was diagnosed as hypermobile, her grandmother (mother’s side) had prob-
lems with her heart valves and her great-grandmother (mother’s side) died early of heart 
valve insufficiency. The patient herself presented with a normal cardiography and no appar-
ent involvement of other organ systems. We analyzed skin biopsies from the patient taken 
from her affected upper body (neck) and from her unaffected lower body (thigh).  
Materials and Methods 
Skin Biopsies and Light Microscopy 
Four skin biopsies were obtained with a 4-mm dermal punch biopsy needle. The skin 
was sterilized and anesthetized with 2 ml of lidocaine (1%) before the biopsy was taken. 
Biopsies for cell cultures, transmission electron microscopy (TEM) and real-time RT-PCR 
were divided into 2 equal parts cut in the superficial-profound direction. One part was used 
for cell cultures, while the other was further divided for TEM and real-time RT-PCR after 
removal of the epidermis. Samples for TEM were fixed at 4°C in 2% glutaraldehyde (in 0.05 
M phosphate buffer) and samples for real-time RT-PCR were stored at –80°C until further 
analyses. New biopsies, following the same procedures and taken from the same areas, were 
obtained for light microscopy. These biopsies were kept in formalin before preparation for 
histological examination, underwent standard preparation and were stained using hematox-
ylin and eosin to demonstrate overall histology as well as Van Gieson’s staining to visualize 
elastic fiber distribution and appearance. Unfortunately, it was not possible to stain elastin 
in light microscopy, and therefore these results are not shown. 
Transmission Electron Microscopy 
Skin samples for TEM were postfixed in 1% OsO4 in 0.12 M sodium cacodylate buffer 
(pH 7.2) for 2 h. The specimens were then dehydrated in graded series of ethanol, trans-
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ferred to propylene oxide and embedded in Epon (Hexion, Houston, Tex., USA) according to 
standard procedures. Ultrathin sections were cut with a Reichert-Jung Ultracut E microtome, 
collected on Formvar membranes and stained with uranyl acetate and lead citrate. Digital 
images were obtained with a Philips CM100TEM (80 kV) equipped with a SIS MegaView2 
camera. 
RNA Extraction 
Skin tissue from the patient (upper and lower body) and skin tissue from 16 young, 
healthy females (lower body), which served as reference, were homogenized in 1 ml of Tri-
Reagent (Molecular Research Center, Inc., Cincinnati, Ohio, USA) containing 5 stainless steel 
balls of 2.3 mm in diameter (BioSpec Products, Inc., Bartlesville, Okla., USA), and 5 silicon-
carbide sharp particles of 1 mm (BioSpec Products, Inc.) by shaking in a FastPrep®-24 in-
strument (MP Biomedicals, Inc, France) at speed level 4 for 15 s. In order to obtain complete 
tissue homogenization, the shaking process was repeated 3 times with ice cooling between 
each shaking step to avoid heating of the sample. Following homogenization, bromo-
chloropropane was added in order to separate the samples into an aqueous and an organic 
phase. Following isolation of the aqueous phase, RNA was precipitated using isopropanol 
with glycogen for co-precipitation. The RNA pellet was then washed in ethanol and subse-
quently dissolved in 20 μl RNAse-free water. Total RNA concentrations were determined by 
Ribogreen assay kit (Invitrogen).  
Real Time RT-PCR 
30 ng total RNA was converted into cDNA in 20 μl using the SensiScript reverse tran-
scriptase (Qiagen, Valencia, Calif., USA) and 1 μM poly-dT (Invitrogen) according to the man-
ufacture’s protocol (Qiagen). For each target mRNA, 0.5 μl of cDNA (5 μl of a 10-fold dilution) 
was amplified in a 25-μl SYBR Green PCR reaction containing 1× Quantitect SYBR Green 
Master Mix (Qiagen) and 100 nM of each primer (table 1). The amplification was monitored 
real-time using the MX3005P Real-time PCR machine (Stratagene, Santa Clara, Calif., USA). 
The Ct values were related to a standard curve made with known concentrations of DNA 
oligos (UltramerTM oligos, Integrated DNA Technologies, Inc., Leuven, Belgium) with a DNA 
sequence corresponding to the sequence of the expected PCR product. Based on these Ct 
values, and accounting for the PCR efficiency, the relative difference between unknown sam-
ples was determined. The specificity of the PCR products was confirmed by comparing the 
melt curves for the unknown samples with melt curves of the DNA oligos. GAPDH was cho-
sen as internal control. 
Western Blotting 
Dermal fibroblasts from the upper affected and lower unaffected body of the patient, as 
well as dermal fibroblasts from the breast of a control female [age 25 years (ATCC-PCS-201–
012)] were grown in 100 mm2 dishes, harvested by trypsination and lysed in 0.1 ml of M-
PER mammalian protein extraction reagent (Thermo Scientific, Rockford, Ill., USA), with 
added Halt protease and phosphatase inhibitor (Thermo Scientific) for 30 min on ice. Ex-
tracts were made from three separate plates for each of the three cells lines. These extracts 
were centrifuged at 12,000 g for 10 min and the supernatant was collected. The protein ex-
tracts were mixed with an equal volume of 2× tris-glycine SDS samples buffer (Invitrogen-
Life Technologies, Carlsbad, Calif., USA) and 20 µg separated on a 12% Mini-PROTEAN®TGX 
precast polyacrylamide gels (Bio-Rad, Hercules, Calif., USA). The following primary antibod-
ies were used: tropoelastin (PR398; Elastin Products Company, Owensville, Mo., USA), colla-
gen VI (NB120–6588; Novus Biologicals, Littleton, Colo., USA) and actin (ab1801; Abcam, 
D
ow
nl
oa
de
d 
by
: 
Co
pe
nh
ag
en
 U
ni
ve
rs
ity
 L
ib
ra
ry
   
   
   
   
   
   
   
   
  
13
0.
22
5.
17
8.
2 
- 1
0/
5/
20
16
 1
1:
18
:2
7 
AM
45 
 
Case Rep Dermatol 2016;8:42–51 
DOI: 10.1159/000443696 
 
© 2016 The Author(s). Published by S. Karger AG, Basel 
www.karger.com/cde 
Nygaard et al.: Acquired Localized Cutis Laxa due to Increased Elastin Turnover 
 
 
 
Cambridge, Mass., USA) as a loading control. Secondary HRP-conjugated antibodies and 
Pierce ECL2 (Thermo Scientific) were used to visualize the protein bands on high perfor-
mance chemiluminescence film (GE Healthcare, Pittsburgh, Pa., USA). The films were 
scanned and saved as 16-bit greyscale tiff files. Densitometric quantification (number of 
square pixels in the selected protein bands) was performed using ImageJ software (NIH, 
Bethesda, Md., USA). 
Immunofluorescence 
Dermal fibroblasts from the upper and lower body of the patient, as well as dermal fi-
broblasts from the breast of a control female [age 25 years (ATCC-PCS-201–012)] were 
seeded in covered slides (Lab-Tek II CC2 chamber slides, 4 well; Thermo Fisher, Rochester, 
N.Y., USA) at 50,000 cells per well and grown for 6 days. The cells were washed twice with 
PBS and fixed with 4% formaldehyde (Polyscience, Warrington, Pa., USA) for 15 min at room 
temperature, and then washed twice with PBS and blocked overnight at 4°C in 1% bovine 
serum albumin in PBS. The fixed cells were then incubated with rabbit anti-tropoelastin 
antibody (Elastin Products Company) in 1% bovine serum albumin in PBS (diluted 1:1,000) 
for 2 h at room temperature. The cells were also incubated with normal rabbit IgG in place of 
the primary antibody as a background control. After two washes with PBS, the cells were 
incubated with Alexa Fluor 568 goat anti-rabbit antibody (Invitrogen-Life Technologies) and 
diluted at 1:2,000 in 1% bovine serum albumin in PBS for 1 h at room temperature. The 
slides were mounted with DAPI (4′,6′-diamidino-2-phenylindole)-containing Vectashield 
(Vector Laboratories, Burlingame, Calif., USA) and analyzed by using a Zeiss Axiovert 200 M 
microscope, with a ×10 objective lens magnification for all images. Three separate experi-
ments were performed and the immunofluorescence intensities were measured using Im-
ageJ software.  
Cell Culture 
Biopsies from the upper and lower body were minced and grown in 35 mm2 dishes in 
DMEM GlutaMAX-1 medium (Gibco Life Technologies, Carlsbad, Calif., USA) supplemented 
with 10% fetal bovine serum (Gibco Life Technologies), 50 U/ml of penicillin and 50 µg/ml 
of streptomycin at 37°C under an atmosphere of 5% CO2 and 20% O2. The medium was 
changed every 8 days until confluence (30 days). The cells were then passaged every 8 days, 
seeding at 1 × 106 cells/plate. Growth curves and survival assays were performed on pas-
sage 4 cells. Cell proliferation assays were performed in either 96-well dishes using wst-1 
cell proliferation reagent, according to the manufacturer’s protocol (Roche, Mannheim, Ger-
many), as an estimate of relative viable cell number, or in 6-well dishes using a hemocytome-
ter to count the cells. In the case of the 96-well format, the cells were seeded (at replicates of 
6 wells per cell type for each day the cell numbers were to be estimated) at either 1,000 cells 
per well in 100 μl of medium or 5,000 cells per well in 100 μl of medium, to estimate prolif-
eration during the logarithmic phase or plateau phase, respectively. The cell numbers were 
estimated using wst-1 cell proliferation reagent every day at the same time for the indicated 
days; 10 μl of wst-1 was added into the 100 μl of medium in each well and left to incubate for 
3 h before reading absorbance (480 nm minus reading at 595 nm). In the case of the 6-well 
format, cells were seeded at 25,000 cells per well and the cell number was counted every 
day at the same time (using the hemocytometer). For the cytotoxicity assays, 10,000 cells 
were plated in replicates of 6 onto 96-well dishes. After 24 h of incubation, the cells were 
washed in PBS and exposed to UVB at 8 J/m2/s for time periods that result in the indicated 
doses, or to H2O2 (dissolved in DMEM GlutaMAX) over a range of H2O2 concentrations for 3 h. 
At the end of the treatments, the cells were washed with PBS, and 100 μl of fresh medium 
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was added. In the case of UVB, the cells were then left to incubate for 36 h before adding 10 
μl of wst-1, and in the case of the H2O2 assay, the wst-1 was added right away. 
Results 
Transmission Electron Microscopy 
Dermal collagen fibrils appeared normal from both affected and unaffected skin, but we 
were unable to detect any elastic fibers in the skin from the affected upper body. Normal 
appearing elastic fibers and collagen fibrils were found in the biopsy from the unaffected 
lower body (images not shown). 
Skin mRNA Expression of Elastin and Collagen 
The elastin mRNA expression appeared to be higher in the affected upper body (table 2), 
while remaining within the range of the reference samples (table 2). Collagen expression 
(COL1A1, COL3A1, and COL5A2) also appeared similar in the two regions (table 2). The total 
amount of RNA was higher in the sample from the affected upper body compared both to the 
unaffected lower body and the reference samples (upper body: 713, lower body: 83, refer-
ence (mean ± standard deviation): 90 ± 82 µg total RNA per mg sample). 
Protein Levels of Elastin 
Results of western blotting from skin biopsies are shown in figure 2. They revealed a 
normal tropoelastin protein band at ~75 kDa (‘tropoelastin 1’) and a shortened tropoelastin 
protein band observed at ~65 kDa (‘tropoelastin 2’). The latter was assumed to be a cleavage 
or degradation product from tropoelastin. Both bands were observed in cells from upper 
and lower body and in the control cells. However, tropoelastin 2 and the combined level of 
the two bands (‘total tropoelastin’ = tropoelastin 1 + 2) were more abundant in cells from 
the upper body compared to both the lower body and the control sample. The levels of colla-
gen VI protein (observed at ~135 kDa) were similar in cells from the upper and lower body 
and from the control sample.  
Tissue Deposition of Elastin 
Skin fibroblasts from the affected upper body grown in culture had a greater capacity to 
deposit elastin in the extracellular matrix relative to the cells from the unaffected lower body 
(fig. 3). However, cells from both regions appeared to have irregular elastin extracellular 
matrix deposition relative to the control sample with normal fibroblasts (fig. 3).  
Cell Proliferation and Survival 
Skin fibroblasts from the affected upper body proliferated faster and reached a higher 
density in culture than skin cells from the unaffected lower body. Furthermore, the skin cells 
from the upper body had enhanced survival after UVB light exposure and oxidative stress 
(H2O2). No apparent differences in speed or level of senescence development were observed 
between skin fibroblasts from the upper and lower body (data not shown). 
Discussion 
Our patient had clinical signs of acquired localized cutis laxa. The phenotypic presenta-
tion of the patient fitted with our microscopic findings of no elastic fibers in the skin of her 
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affected upper body. We did, however, find higher levels of elastin mRNA expression in the 
affected skin area compared to the unaffected area. It could be speculated that this reflects 
an attempt of the fibroblasts to compensate for the low amount of elastic fibers in the tissue. 
This could also fit with the increased amount of total RNA in the skin cells of the affected 
area. From our results, we cannot ascertain why the elastin mRNA product does not end up 
in the tissue as elastic fibers, but since we found no elastic fibers with tissue microscopy, this 
discrepancy must be due to either mutation, inefficient translation of the mRNA or degrada-
tion of the protein.  
In the cell cultures, we found increased protein levels of tropoelastin, but protein from 
the affected area seemed fragmented, and this could explain the dysfunctional nature of the 
elastin. Degradation of the protein has previously been described in relation to inflammatory 
reactions [6, 7], but the mechanism is described as generalized cutis laxa indicating either a 
local promoting factor in the diseased skin or a compensatory one in the normal skin of the 
patient. The cell culture experiments indicated that skin fibroblasts from the affected area 
behaved differently, under normal and stress conditions, from skin fibroblasts of the unaf-
fected area. Fibroblasts taken from affected skin showed increased proliferation under typi-
cal growth conditions of 20% oxygen and enhanced cell survival after exposure to UVB light 
and oxidative stress (H2O2). Interestingly, increases in elastin levels after ultraviolet irradia-
tion have previously been shown to occur in normal dermal fibroblasts [8, 9]. Our findings of 
increased cell proliferation in the affected area without elastic fibers fit with findings in 
transgenic mice with a total lack of elastin (Eln–/–) and in patients with confirmed elastin 
haploinsufficiency, where increased cell proliferation has also been observed [10–12]. These 
findings suggest that elastin could have a negative influence on cell proliferation rates. 
In conclusion, we report an adult female with the rare condition of localized acquired 
cutis laxa. The disease affected the skin of her upper body, and skin biopsies revealed an 
absence of elastic fibers in the dermis, despite high amounts of elastin mRNA expression and 
protein levels as well as high proliferative rates of skin fibroblasts.  
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Table 1. Primer sequences 
    
    
mRNA Sense primer Anti-sense primer NM 
    
    
GAPDH CCTCCTGCACCACCAACTGCTT GAGGGGCCATCCACAGTCTTCT NM_002046.4 
COL1A1 GGCAACAGCCGCTTCACCTAC GCGGGAGGACTTGGTGGTTTT NM_000088.3 
COL3A1 CACGGAAACACTGGTGGACAGATT ATGCCAGCTGCACATCAAGGAC NM_000090.3 
COL5A2 CTGTGGTTCTCAAAGGGGCAAA AGACAGTCTTGCCCACATTTCCATT NM_000393.3 
Elastin GGCTTCGGATTGTCTCCCATTTT CCAACGTTGATGAGGTCGTGAG NM_000501.3 
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Table 2. mRNA results 
    
    
 Upper body Lower body Reference range 
    
    
COL1A1 6.34 8.06 1 (0.08–12.50) 
COL3A1 6.29 3.98 1 (0.07–15.37) 
COL5A2 2.75 3.60 1 (0.11–8.97) 
Elastin 6.56 2.05 1 (0.14–7.08) 
    
    
All values are relative to GAPDH expression, and the geometric mean 
for the reference is set as 1. 
    
 
 
 
 
 
Fig. 1. Patient phenotype. a The patient (left) and her mother (right). b Note the redundant, sagging and 
inelastic appearance of the skin of the patient. 
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Fig. 2. a Western blotting. The figure shows western blot results from cells of the affected upper body and 
unaffected lower body, as well as from a control 25-year-old female (normal fibroblasts). The cells from 
the upper body had higher levels of the short band detected by the tropoelastin antibody (tropoelastin 2) 
and higher levels of the total tropoelastin (tropoelastin 1 + 2). b Error bars represent the average band 
intensities (normalized to actin) from the three replicates shown ± standard deviation.  
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Fig. 3. a Immunohistochemistry. The skin biopsies from the affected upper and unaffected lower body, as 
well as from a normal female were tested for elastin deposition by immunofluorescence. Cells were grown 
in covered slides for 6 days and then stained for tropoelastin. Intensity was quantified by ImageJ software. 
b Error bars represent the average intensity (corrected for actin) of three replicates (lysates from sepa-
rate plates) ± standard deviation. The cells were also stained with DAPI to visualize cell nuclei (blue). 
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